-
MannKind Is Plummeting
Tuesday, January 5, 2016 - 10:19am | 172Read More...Shares of MannKind Corporation (NASDAQ: MNKD) plummeted more than 40 percent Tuesday morning after the company announced the termination of its licence and collaboration agreement with Sanofi SA (ADR) (NYSE: SNY). The prior agreement consisted of the development and commercialization of Afrezza...
-
Regeneron Shares Rising After Sanofi Collaboration Revealed: Good News For Shareholders?
Tuesday, July 28, 2015 - 1:57pm | 429Read More...Shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) were trading higher by more than 3 percent Tuesday after the company announced a new global collaboration with Sanofi (NYSE: SNY) to "discover, develop and commercialize new antibody cancer treatments in the emerging field of immune-...
-
MannKind 'Facing Low Profitability And Delayed Profits' As Afrezza Ramp Fizzles, Goldman Says
Monday, May 11, 2015 - 3:35pm | 264Read More...MannKind Corporation (NASDAQ: MNKD) shares fell 5 percent Monday after JP Morgan downgraded the stock from Neutral to Underweight. The demotion followed last Friday’s earnings release, which disappointed many investors and analysts. Jefferies analyst Shaunak Deepak maintained a Buy rating...
-
Piper Jaffray Dishes On MannKind's Afrezza Data
Monday, May 11, 2015 - 11:52am | 601Read More...MannKind Corporation (NASDAQ: MNKD) reported first quarter 2015 results on May 7, revealing underwhelming sales and a mediocre Afrezza launch. Shares of MannKind last closed at $4.02, just above the 52-week low of $3.52. Some analysts are beginning to doubt if the company can make a comeback....
-
Regeneron Earnings: Small Growth Expected, Driven By Eylea
Wednesday, May 6, 2015 - 5:30pm | 385Read More...Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is scheduled to announce its first quarter financial results on Thursday, and both the crowd and experts expect to see some growth, although the Street is slightly more bullish. According to Estimize, Wall Street analysts model consensus earnings of...
-
What's Afrezza's Ultimate Potential For MannKind?
Thursday, April 16, 2015 - 11:39am | 251Read More...In a report published Thursday, RBC Capital Markets analyst Adnan Butt commented that MannKind Corporation (NASDAQ: MNKD) has seen its Afrezza slow to take off and first quarter sales are likely to miss consensus estimates. Butt noted that the consensus estimate for MannKind is approximately $3.9...
-
Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger
Monday, January 12, 2015 - 4:44pm | 180Read More...Speaking to Benzinga, Griffin Securities Analyst Dr. Keith Markey said that after MannKind Corporation (NASDAQ: MNKD) founder Alfred Mann retires from his role as CEO, the new management will probably not pursue a merger with Sanofi SA (ADR) (NYSE: SNY). "I think what they’re going...
-
These 2 Dodge & Cox Funds Are Big Hewlett-Packard Owners
Tuesday, December 2, 2014 - 3:44pm | 462Read More...When companies report earnings, big institutional owners such as mutual funds look for an opportunity to either add to or pare positions. Post-earnings price movements driven by funds are most evident in smaller or younger stocks, which tend to be more volatile. However, even when a widely...
-
Dow, S&P 500 Close At Record Highs In Another Quiet Trading Session
Thursday, November 20, 2014 - 5:52pm | 1021Read More...U.S. stocks brushed off early morning losses and ended the day slightly positive. U.S. economic data showed existing home sales and leading indicators both being higher than expected for October, while U.S. preliminary PMI fell from October's reading as analysts were expecting a rise. On...
-
Perrigo Surges Amid Report Of Omega Pharma Acquisition
Thursday, October 30, 2014 - 11:17am | 301Read More...Shares of Perrigo Company plc (NYSE: PRGO) surged higher Thursday amid reports that the company will buy Omega Pharma NV. Bloomberg reported that "Perrigo Co. has entered exclusive talks to buy Omega Pharma NV after beating suitors including Sanofi, Actavis Plc and Boehringer Ingelheim...
-
QE Finally Ends
Wednesday, October 29, 2014 - 4:56pm | 1693Read More...U.S. stocks were marginally lower as traders and investors begin debating the effects of the markets in an uncertain post Quantitative Easing era. The FOMC has officially tapered the remaining $15 billion of its monthly asset purchases, thus ending the era of quantitative easing for the time...
-
Markets Continue To Rally As The Dow Closes Above 17,000
Tuesday, October 28, 2014 - 4:44pm | 1552Read More...U.S. stocks continued to charge forward as the Dow closed above the 17,000 mark as consumer confidence rose more than expected in October. The Federal Reserve gathered Tuesday and will release a statement on Wednesday at 2:00 p.m. ET. It is not a foregone conclusion that the Federal Reserve...
-
Markets Rally On Fed Minutes, Alcoa Kicks Off Earnings Season With Strong Beat
Wednesday, October 8, 2014 - 5:14pm | 2148Read More...U.S. stocks rallied after the 2:00 PM release of the Fed's September minutes, which revealed that committee members continue to debate over the timing and language of a rate hike. Several officials questioned their guidance if short-term rates were likely to stay low for a “...
-
Unilife Corp Shares Continue To Rise Following Sanofi Deal
Wednesday, October 8, 2014 - 11:58am | 135Read More...Shares of Unilife Corp (NASDAQ: UNIS) have appreciated over 100 percent in the past four trading sessions after the company announced a long-term supply agreement with Sanofi valued at $50 million. Under the terms of the agreement, Unilife will be the sole provider of cartridge-based wearable...
-
Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments
Monday, August 11, 2014 - 4:46pm | 2480Read More...U.S. markets managed to squeeze out small gains in lighter than normal volume, as geopolitical tensions may be calming down. Russia President Vladimir Putin said that the country will coordinate with the International Red Cross to send humanitarian aid to Ukraine. Meanwhile, Palestinians and...
